Safety and Tolerability of RTX-134 in Adults With Phenylketonuria
Clinical trial NCT04110496 · TERMINATED
Trial details
- NCT number
- NCT04110496
- Sponsor
- Rubius Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2022-12-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.